Steven A. Leibel
#139,828
Most Influential Person Now
Steven A. Leibel's AcademicInfluence.com Rankings
Download Badge
Physics
Why Is Steven A. Leibel Influential?
(Suggest an Edit or Addition)Steven A. Leibel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. (1994) (1122)
- Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. (2000) (946)
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. (2002) (831)
- High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. (2001) (726)
- Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. (1999) (622)
- DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER (1998) (616)
- Imaging prostate cancer: a multidisciplinary perspective. (2007) (602)
- Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. (2000) (565)
- Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004) (516)
- Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. (2006) (449)
- The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. (1991) (448)
- The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. (2000) (403)
- Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. (1996) (387)
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. (1999) (379)
- Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. (1989) (368)
- Radiation therapy for neoplasms of the brain. (1987) (352)
- Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. (1996) (328)
- Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. (2000) (328)
- Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma (1999) (327)
- Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. (1997) (321)
- Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. (2000) (318)
- Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. (2000) (311)
- Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. (2001) (304)
- Clinically relevant optimization of 3-D conformal treatments. (1992) (297)
- Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. (2002) (295)
- Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. (1999) (252)
- Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. (1999) (248)
- Fluoroscopic evaluation of diaphragmatic motion reduction with a respiratory gated radiotherapy system (2001) (247)
- Carcinoma of the major and minor salivary glands. Analysis of treatment results and sites and causes of failures (1977) (246)
- Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. (2004) (245)
- Radiation Injury to the Nervous System (1991) (241)
- The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. (1991) (231)
- Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer (1999) (216)
- Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. (1989) (210)
- Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. (1997) (207)
- The role of radiation therapy in the treatment of astrocytomas (1975) (207)
- Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. (1997) (206)
- Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. (2001) (205)
- Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. (2003) (203)
- Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. (1987) (195)
- Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. (1984) (195)
- Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma (2005) (188)
- External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. (1991) (188)
- Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. (2001) (188)
- Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. (1995) (188)
- Potency after permanent prostate brachytherapy for localized prostate cancer. (2001) (184)
- Comprehensive QA for Radiation Oncology (1994) (179)
- Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. (1994) (178)
- Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? (2005) (170)
- Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. (1997) (170)
- Soft tissue sarcomas of the extremities. Survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone (1982) (169)
- Textbook of Radiation Oncology (1998) (168)
- Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. (1984) (168)
- Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. (2003) (165)
- Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. (1994) (163)
- Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. (2005) (163)
- Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. (2004) (155)
- Intensity-modulated radiotherapy. (2002) (154)
- Selection bias, survival, and brachytherapy for glioma. (1992) (154)
- Intensity-modulated Stereotactic Radiotherapy of Paraspinal Tumors: A Preliminary Report (2004) (149)
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. (1999) (144)
- Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. (2005) (144)
- Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease. (1985) (144)
- The biological basis for conformal three-dimensional radiation therapy. (1991) (143)
- Desmoid tumors: local control and patterns of relapse following radiation therapy. (1983) (142)
- Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. (1985) (141)
- Postoperative radiotherapy of primary spinal cord tumors. (1989) (140)
- Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. (1993) (138)
- A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. (1996) (134)
- Intensity-modulated radiation therapy for prostate cancer. (2002) (134)
- Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. (1991) (132)
- Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. (1997) (129)
- Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. (2000) (128)
- The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. (1993) (128)
- Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. (1999) (125)
- Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. (1995) (123)
- Contemporary approaches to the treatment of malignant gliomas with radiation therapy. (1994) (122)
- Principles and Practice of Genitourinary Oncology (1997) (120)
- The potential and limitations of the inverse radiotherapy technique. (1994) (120)
- IMRT of large fields: whole-abdomen irradiation. (2001) (118)
- Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. (1994) (117)
- The effect of setup uncertainties on the treatment of nasopharynx cancer. (1993) (116)
- Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. (1997) (115)
- Intensity modulated radiotherapy in high grade gliomas: Clinical and dosimetric results. (2006) (114)
- Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. (2005) (108)
- The dissemination of cancer by transurethral resection of locally advanced prostate cancer. (1983) (103)
- Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. (2003) (97)
- Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. (1995) (97)
- The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. (1994) (96)
- Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy (1993) (94)
- Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. (2002) (94)
- Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. (2004) (93)
- 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study. (1989) (92)
- The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. (1997) (91)
- Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. (2001) (88)
- Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. (2003) (87)
- Three-dimensional conformal radiotherapy and dose escalation: where do we stand? (1998) (86)
- The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. (1994) (85)
- A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. (1987) (83)
- Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. (1998) (80)
- Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. (2000) (80)
- The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. (1995) (79)
- Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. (2001) (79)
- Esthesioneuroblastoma: Is there a role for elective neck treatment? (1991) (79)
- Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. (2003) (78)
- The definition of biochemical failure in patients treated with definitive radiotherapy. (2000) (77)
- Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. (2000) (77)
- Desmoid tumors--treatment and prognosis. (1977) (75)
- Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. (1999) (75)
- Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study. (1998) (74)
- Computerized design of target margins for treatment uncertainties in conformal radiotherapy. (1999) (74)
- Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era. (1996) (73)
- Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. (1987) (73)
- Postoperative radiation for lung cancer metastatic to the brain. (1994) (73)
- Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. (1999) (72)
- Tolerance of the brain and spinal cord to conventional irradiation (1991) (71)
- Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial. (1987) (69)
- Isotope selection for patients undergoing prostate brachytherapy. (1999) (68)
- Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy (1992) (67)
- Induction chemotherapy in advanced head and neck cancer. A Radiation Therapy Oncology Group Study. (1987) (67)
- Interstitial brachytherapy for metastatic brain tumors (1989) (66)
- Stereotaxic irradiation of brain tumors (1990) (63)
- Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer. (2000) (63)
- Leibel and Phillips textbook of radiation oncology (2010) (60)
- Radiation therapy for relapsed CNS germinoma after primary chemotherapy. (1998) (60)
- A feasibility study of automated inverse treatment planning for cancer of the prostate. (1998) (56)
- Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer. (2001) (55)
- Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer. (1995) (54)
- Down-regulation of ATM Protein Sensitizes Human Prostate Cancer Cells to Radiation-induced Apoptosis* (2005) (52)
- Three dimensional conformal treatment planning with multileaf collimators. (1995) (51)
- Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. (2002) (51)
- Preliminary results of conformal radiation therapy for medulloblastoma. (1999) (49)
- Variation in prostate position: Quantitation and implications for three-dimensional conformal radiation therapy (1993) (48)
- Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients (2003) (48)
- The value of ultrasonic imaging and CT scanning in planning the radiotherapy for prostatic carcinoma (1978) (47)
- Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. (1999) (46)
- Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. (2003) (46)
- A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study. (1991) (45)
- The treatment of meningiomas in childhood (1976) (44)
- Treatment of osteogenic sarcoma of the mandible. (1979) (43)
- Three-dimensional conformal treatment: a new frontier in radiation therapy. (1991) (43)
- Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. (2004) (41)
- Tolerance of the Central and Peripheral Nervous System to Therapeutic Irradiation (1987) (41)
- A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. (2003) (41)
- Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. (2000) (40)
- A CT-based computerized treatment planning system for I-125 stereotactic brain implants. (1990) (40)
- Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer. (1999) (38)
- High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated. (2004) (37)
- Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy. (2002) (37)
- Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01. (1991) (37)
- Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study. (1987) (35)
- Hepatic giant cell carcinoma. An ultrastructural and immunohistochemical study. (1990) (35)
- Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. (2000) (33)
- Intracranial Tumors : Diagnosis and Treatment (2002) (31)
- A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer. (1992) (31)
- Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (31)
- The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. (1995) (30)
- Twice‐daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the radiation therapy oncology group 88—05 (1994) (30)
- Initial clinical experience with computer-controlled conformal radiotherapy of the prostate using a 50-MeV medical microtron. (1994) (28)
- Phase I dose escalation study using the deep inspiration breath hold technique to safely increase dose to 81 Gy in the treatment of inoperable non-small cell lung cancer (2000) (28)
- Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. (1989) (28)
- Stereotaxic interstitial irradiation of malignant brain tumors. (1985) (28)
- A survival model for fractionated radiotherapy with an application to prostate cancer. (2001) (27)
- The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy. (2003) (27)
- Local control and reduced complications in split course irradiation of prostatic cancer. (1981) (27)
- New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate. (1996) (26)
- Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction. (2001) (26)
- Vaginal and paraaortic lymph node metastases in carcinoma of the endometrium. (1980) (26)
- Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer (2003) (25)
- Statin use is associated with improved biochemical outcome after high-dose radiotherapy for clinically localized prostate cancer (2003) (23)
- Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbits. (1980) (23)
- The management of malignant gliomas with radiation therapy: Therapeutic results and research strategies (1991) (21)
- The potential and limitations of the inverse radiotherapy technique (1995) (20)
- Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer. (2004) (20)
- Perspectives of multidimensional conformal radiation treatment. (1993) (20)
- Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies. (1990) (20)
- Early observations of acute and chronic toxicity & psa response in patients with carcinoma of the prostate treated on a dose escalation study with 3D-CRT (1994) (19)
- 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center. (1996) (19)
- Conformal three dimensional treatment planning may improve the therapeutic ratio of high dose radiation therapy for lung cancer (1991) (19)
- Preclinical evaluation of the reliability of a 50 MeV racetrack microtron. (1994) (19)
- Is local failure a cause of or a marker for metastatic dissemination in carcinoma of the uterine cervix? (1992) (18)
- Squamous cell carcinoma of the head and neck after radiation therapy for Hodgkin's disease a report of two cases and a review of the literature (1985) (18)
- Routine editing of trainee-generated radiology reports: effect on style quality. (2003) (18)
- A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma (2002) (17)
- Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole. (1983) (17)
- 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. (1996) (17)
- New methods applied to the analysis and treatment of ovarian cancer. (1978) (16)
- Ten-year results of dose escalation with 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer (2003) (16)
- The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole. (1989) (15)
- Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (15)
- 1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume? (1999) (15)
- Combined 3‐dimensional conformal radiotherapy and transperineal Pd‐103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer (2000) (15)
- Twice daily thoracic irradiation for limited small cell lung cancer. (1991) (14)
- Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial. (1986) (14)
- Tumor Motion Control in the Treatment of Non Small Cell Lung Cancer (2005) (14)
- Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study. (1981) (14)
- Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials--results of the Radiation Therapy Oncology Group (RTOG) analysis. (1995) (14)
- Conjecture on the use of high energy electrons for conformal radiotherapy (1992) (13)
- Local control is associated with decreased distant failure in early stage carcinoma of the prostate (1989) (13)
- Chemotherapy following Surgery for Head and Neck Cancer: A Radiation Therapy Oncology Group Study (1989) (13)
- Radiolabeled antibody in the treatment of primary and metastatic liver malignancies. (1986) (12)
- Is pelvic radiation necessary in patients undergoing prostate brachytherapy (1998) (12)
- Pre-irradiation evaluation and management of brain metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (12)
- High dose rate gynecological applications - radiobiological considerations based on the α-β model (1992) (11)
- Decision‐making in radiotherapy for the cancer patient: The American College of Radiology Appropriateness Criteria Project (1998) (11)
- Conservative surgery and radiation in the treatment of stage I and II carcinoma of the breast. American College of Radiology. ACR Appropriateness Criteria. (2000) (11)
- Intensity modulated radiotherapy for soft tissue sarcoma of thigh (2002) (11)
- The integration of new therapies and radiation in the management of ovarian cancer (1981) (10)
- The use of port films from multiple projections to determine the spatial distribution of setup errors for prostate cancer patients (1994) (10)
- Follow-up and retreatment of brain metastasis. American College of Radiology. ACR Appropriateness Criteria. (2000) (10)
- Acute morbidity and PSA response in patients with carcinoma of the prostate treated with three dimensional conformal radiation therapy (1992) (10)
- A versatile method for planning stereotactic brain implants. (1993) (10)
- ACR appropriateness criteria (1999) (10)
- Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. (1993) (10)
- Impact of Transurethral Resection on the Long-Term Outcome of Patients with Prostatic Carcinoma (1993) (9)
- Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer (1998) (9)
- Initial clinical experience with computer-controlled conformal radiotherapy using the MM50 microtron (1993) (9)
- Three-dimensional conformal radiation therapy (3D-CRT) for early-stage non-small-cell lung cancer. (2001) (9)
- Conventional external beam radiation therapy for prostatic cancer: where do we go from here? (1993) (9)
- 112 The deep inspiration breath[ hold technique for the treatment of lung cancer: The first 200 treatments (1999) (9)
- Maintenance of certification for radiation oncology. (2005) (9)
- The Impact of Local Tumor Control on the Outcome in Human Cancer (1993) (9)
- Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms (1998) (8)
- 76 Impact of radiation dose on achieving nadir PSA levels after 3-dimensional conformal radiotherapy for patients with localized prostate cancer (1996) (8)
- Inclusion of systematic setup uncertainties in treatment plans (1994) (8)
- Abstract of ASTRO Scientific paper to be presentedInterstitial implantation of high-activity iodine-125 sources for the treatment of recurrent malignant brain tumors (1984) (8)
- Incorporation of organ motion uncertainties into 3d prostate treatment plans (1994) (7)
- Soft tissue sarcomas of the extremities: Survival and patterns of failure with conservative surgery and post-operative irradiation compared to surgery alone (1981) (7)
- Feasibility study of using low-energy intensity modulated radiation for the treatment of localized prostate carcinoma to high doses (2000) (7)
- 78 The potential of optimized intensity modulation to escalate prostate dose to 86.4 GY (1996) (7)
- Salvage whole-abdominal irradiation following chemotherapy failure in epithelial ovarian carcinoma. (1990) (7)
- Comparing contemporary surgery to external-beam radiotherapy for clinically localized prostate cancer. (2002) (6)
- Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (6)
- Coping with prostate and seminal vesicle motion in three-dimensional conformal radiation therapy (1994) (6)
- Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria. (2000) (6)
- Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (6)
- Bone metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (6)
- Radiotherapy for lung cancer: can IMRT decrease the risk of esophagitis (2001) (6)
- Long-term outcome of high dose intensity modulated radiotherapy for clinically localized prostate cancer (2004) (5)
- Stereotaxic interstitial implantation for the treatment of malignant brain tumors (1986) (5)
- Brachytherapy with Removable Iodine-125 Sources for the Treatment of Recurrent Malignant Brain Tumors (1984) (5)
- The integration of tumor associated antigens in cancer management. (1981) (5)
- Advances in precision treatment: some aspects of 3D conformal radiation therapy. (1993) (5)
- Radiation Therapy of Hepatobiliary Tumors (1985) (5)
- ACR appropriateness criteria. Expert Panel on Radiation Oncology. American College of Radiology. (1999) (4)
- 46 Improved conformality and reduced toxicity with high-dose intensity modulated radiation therapy (IMRT) for patients with prostate cancer (1999) (4)
- Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
- Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
- Solitary brain metastasis. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
- Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
- 29 Mixed modality intensity-modulated radiation therapy treatment planning for intracranial lesions (1997) (4)
- Relationship of the patterns of recurrence to the technical accuracy of stereotactic interstitial implantation for high grade gliomas (1991) (4)
- Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
- Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
- Correlation of long-term biochemical outcome with post-treatment biopsy results for patients treated with 3-dimensional conformal radiotherapy for prostate cancer (2004) (3)
- 1038 Intensity modulated radiation therapy for primary nasopharynx cancer (1999) (3)
- Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
- Comparison of outcome and morbidity of 3-dimensional conformal radiotherapy versus transperineal permanent I-125 implantation for early stage prostatic cancer (1998) (3)
- Stereotaxic interstitial iodine-125 “boost” in the initial management of malignant gliomas (1990) (3)
- STATE OF THE ART : Imaging Prostate Cancer : Multidisciplinary Perspective (2007) (3)
- PCV chemotherapy in anaplastic glioma: A retrospective review of radiation therapy oncology group (RTOG) protocols comparing survival with BCNU or PCV adjuvant chemotherapy (1998) (3)
- 3D Conformal radiation therapy-Treatment planning (1994) (3)
- 1043 Dose escalation for maxillary sinus cancer using intensity-modulated radiation therapy (IMRT) (1997) (3)
- Locally advanced breast cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
- Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
- Positron emission tomography after three-dimensional conformal radiation therapy for non-small cell lung cancer (2001) (3)
- New technologies for the radiotherapy of prostate cancer. A discussion of clinical treatment programs. (2007) (3)
- Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (2)
- Does the registration of FDG-PET and planning CT images decrease inter- and intra-observer variation in delineating tumor volumes for non-small cell lung cancer (NSCLC) (2004) (2)
- Outcome of clinical stage T1c prostate cancer treated with 3-dimensional conformal radiotherapy (1998) (2)
- Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (2)
- International Educational Symposium on Training and Education of Residents in Radiation Oncology. Philadelphia, April 5-6, 1991. (1992) (2)
- Interstitial Brachytherapy for Malignant Brain Tumors: Technique and Results (1988) (2)
- Incorporation of multileaf collimation in clinical 3D conformal treatment planning (1992) (2)
- Predictors o f B iochemical O utcome W ith S alvage C onformal Radiotherapy A fter R adical P rostatectomy f or P rostate C ancer (2003) (2)
- Predictors of post-treatment prostatic biopsy outcome after 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer (2000) (2)
- Principles of successful radiation therapy (1979) (2)
- Evaluation of external-beam radiotherapy treatment plans incorporating treatment uncertainties: a new and essential method for dose-painting IMRT plans for prostate cancer (2002) (2)
- Anal cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (2)
- Risk stratification predicts biochemical outcome after salvage post-prostatectomy three-dimensional conformal radiation therapy (2001) (2)
- Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. (2000) (2)
- Refining the predictive power of the prostate-specific antigen. (1993) (2)
- Analysis of geometric and dosimetric factors that correlate with late rectal bleeding after conformal radiotherapy of prostate cancer (1998) (2)
- New Technologies for the Radiotherapy of Prostate Cancer (2007) (2)
- Does local-regional control affect distant metastatic spread in squamous cell carcinoma of the head and neck? Results of an rtog analysis. (1990) (2)
- 124 Planning, delivery, and quality assurance of treatment with dynamic multileaf collimator for prostate: A strategy for large scale implementation (1996) (1)
- Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
- 1012 Quantification of variation in organ position and volume during conformal radiotherapy of the prostate (1996) (1)
- High dose image guided intensity modulated radiotherapy for primary tumors in close proximity to the spinal cord (2004) (1)
- 100 Risk factors for impotence in patients with carcinoma of the prostate treated with three-dimensional conformal radiation therapy (1995) (1)
- Staging evaluation for patients with Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
- Abstract of ASTRO scientific paper to be presentedPrognostic factors in unresectable hepatocellular cancer: Radiation therapy oncology group (RTOG) study 8301 (1989) (1)
- Prognostic factors for maintained efficacy of Sildenafil citrate in the management of erectile dysfunction after radiotherapy for prostate cancer (2003) (1)
- Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
- Staging of non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
- Computer-Controlled 3D Conformal Radiation Therapy (1995) (1)
- Improved survival following interstitial implantation of removable high-activity iodine-125 sources for malignant recurrent gliomas (1986) (1)
- IMPROVED OUTCOME WITH HIGH DOSE 3-DIMENSIONAL CONFORMAL RADIOTHERAPY: RESULTS OF 1050 PATIENTS TREATED FOR LOCALIZED PROSTATE CANCER (1999) (1)
- Pitfalls in deducing radiobiological parameters for tumors from clinical data: a study of biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer☆ (2000) (1)
- Local regional recurrence and salvage surgery. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
- Improved quality of life following radical radiation therapy for early stage carcinoma of the prostate. (1980) (1)
- Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
- Comprar Leibel and Phillips Textbook of Radiation Oncology, 3rd Edition | Theodore L. Phillips | 9781416058977 | Saunders (2010) (1)
- CLINICAL UROLOGY: Letters to the EditorRE: HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED CANCER (2001) (1)
- Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and distant therapy (1992) (1)
- 25. Interstitial Brachytherapy with Removable High‐Activity Iodine‐125 Sources for Recurrent Malignant Brain Tumors (1985) (1)
- Results of postoperative radiation following resection of lung cancer metastatic to the brain (1993) (1)
- Probability of cure as a function of dose and prognosis category for patients with localized prostate cancer treated with fractionated radiotherapy :an analysis with a novel model of tumor recurrence (2001) (1)
- Severe thrombocytopenia following total body irradiation. (1980) (1)
- Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer (2000) (0)
- DOWN-REGULATION OF ATAXIA-TELANGIECTASIA MUTATED PROTEIN (ATM) SENSITIZES HUMAN PROSTATE CANCER CELLS TO RADIATION-INDUCED APOPTOSIS. with the protein kinase (2005) (0)
- Transcriptional down-regulation of Ataxia-Telangiectasia Mutated protein (ATM) radiosensitizes human prostate cancer cells (2003) (0)
- PSA SCREENING. AUTHORS' REPLY (1994) (0)
- Comparison o f t he 5 -Year O utcome a nd M orbidity of T hree-Dimensiona l C onformal R adiotherapy Versus T ransperineal P ermanent I odine-125 I mplantation for E arly-Stage P rostatic C ancer (1999) (0)
- An in vivo tissue-model of mitotic cell death and EGFR-signaling (2003) (0)
- Results of the pattens of care outcome study in prostate cancer (1981) (0)
- A study of the effects of internal organ motion and setup error on dose escalation in conformal prostate treatments (1998) (0)
- 325Conformal therapy of prostate cancer using intensity-modulated x-rays designed by the inverse technique and produced with dynamic multileaf collimation (1996) (0)
- In response to Drs. Schulz and Kagan (2003) (0)
- Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (0)
- Total dose of twice daily thoracic irradiation and the use of concomitant chemotherapy may be important determinants of outcome for limited stage small-cell lung cancer (1990) (0)
- The radiation therapy oncology group: An update of clinical research activities (1991) (0)
- Predictors of late femoral head toxicity after high-dose 3D-conformal radiotherapy and intensity modulated radiotherapy (2002) (0)
- In response to DRS. Dearnaley, Norman, and Shahidi (2002) (0)
- 1452: Defining the Characteristics of Locally Recurrent Prostate Cancer After Radical Prostatectomy Based on the Results of Salvage Radiotherapy: a Multi-Center Analysis (2004) (0)
- Book review (2004) (0)
- 322Clinical implementation of dynamic multileaf-modulation for intensity-modulated treatments (1996) (0)
- Saturday, May 10, 2003 (S84-S102) (2003) (0)
- In response to Dr. Jenkins (2002) (0)
- Correlation of PSA with long term outcome in patients treated for prostatic carcinoma (1993) (0)
- Adenovirus-mediated antisense KU70 gene transfer increases the radiosensitivity of human malignant gliomas (2002) (0)
- PSA screening. (1994) (0)
- High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model. (1992) (0)
- 1048 Parotid gland sparing using inverse planning for radiotherapy of nasopharyngeal carcinomas (1997) (0)
- 3D in radiotherapy — pushing the dose envelope to improve cure (1996) (0)
- 125 A Monte Carlo approach to the design of target margins for setup errors and organ motion in conformal radiotherapy (1996) (0)
- 119 Use of radiobiological indices to guide dose escalation of the prostate cancer patients (1997) (0)
- Radiolabeled polyclonal antiferritin antibody for the treatment of hepatoma and hodgkin's diseases current results and future strategies (1987) (0)
- 29 A new era in radiotherapy (1995) (0)
- Local control and reduced complications in delayed irradiation of prostatic cancer (1979) (0)
- Using logical combinations of structures as a utility for inverse planning (1998) (0)
- In response to Dr. Jeremic (2002) (0)
- Patterns o f F ailure U sing a C onformal R adiation T herapy Tumor B ed B oost f or M edulloblastoma (2003) (0)
- Magnetic resonance imaging evaluation of radiation-induced changes in experimentally implanted renal cell carcinoma. (1987) (0)
- [Preservation of pregnancy after severe trauma]. (1959) (0)
- Part II Primary Central Nervous System Tumors (2002) (0)
- 2132 Analysis of biopsy outcome after three-dimensional radiation therapy of prostate cancer using dose distribution variables (1999) (0)
- Radionuclides for systemic oncotherapy (1984) (0)
- Chapter 6 – Three-Dimensional and Conformal Treatment Planning (2002) (0)
- 2136 Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostatic adenocarcinoma (1999) (0)
- The Radiation Therapy Oncology Group: an update of clinical research activities. (1991) (0)
- In regard to rosenzweig et al. IJROBP 2001; 50: 681-685. Authors' reply (2002) (0)
- Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer (2003) (0)
- Comprehensive comparison of health-related quality of life after radical prostatectomy, high- dose intensity modulated radiotherapy and intraoperative conformal brachytherapy for localized prostate cancer (2002) (0)
- Microsurgical resection and I-125 brachytherapy for the treatment of previously-irradiated meningiomas and chordomas at the base of the skull (1982) (0)
- Treatment of supratentorial grade III and IV gliomas with short course high dose radiation (1986) (0)
- Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (0)
- Commentary on IMRT and cancer of the prostate. Authors' reply (2003) (0)
- Sequential multimodality therapy of ovarian cancer with new treatment techniques (1979) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Steven A. Leibel?
Steven A. Leibel is affiliated with the following schools:
